Complete Clinical Response following Neoadjuvant Treatment of Stage II Rectal Cancer: Observation of Surgery
DOI:
https://doi.org/10.22516/25007440.436Keywords:
rectal cancer, complete medical response, nonsurgical management, neoadjuvant therapyAbstract
Complete clinical response after neoadjuvant therapy for locally advanced rectal cancer has been considered sufficient for implementation of a non-surgical approach of observation and monitoring by some authors. Standard management of this condition is radical resection of the primary tumor six to ten weeks after completion of neoadjuvant therapy. In this review the pros and cons of each proposal are presented, and implications and recommendations for each alternative are described
Downloads
References
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. Ca Cancer J Clin 2013; 63: 11-30.
Instituto Nacional de Cancerología E.S.E. Anuarios estadísticos 2003 - 2011. Bogotá.
Piñeros M, Pardo C, Gamboa O, et al. Atlas de mortalidad por cáncer en Colombia, tercera edición. Bogotá, 2010. Instituto Nacional de Cancerología E.S.E; Instituto Geográfico Agustín Codazzi.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology, Rectal Cancer, Version 2.2014. URL: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
Van de Velde CJ, Boelens PG, Borras JM, et al. EURECCA colorectal: Multidisciplinary management: European consensus conference Colon & Rectum. Eur J Cancer 2014; 50(1): 1.e1-1.e34.
Meredith KL, Hoffe SE, Shibata D. The multidisciplinary management of rectal cancer. Surg Clin N Am 2009; 89: 177-215.
Glynne-Jones R, Kronfli M. Locally advanced rectal cancer: A comparison of management strategies. Drugs 2011; 71(9): 1153-1177.
Valentini V, Beets-Tan R, Borras JM, et al. Evidence and research in rectal cancer. Radiotherapy and Oncology 2008; 87: 449-474.
McCarthy K, Pearson K, Fulton R, Hewitt J. Quimiorradiación preoperatoria para el cáncer rectal localmente avanzado no metastásico. Cochrane Database of Systematic Reviews 2012 Issue 12. Art. No.: CD008368.
Jeong WL, Jong HL, Jun-Gi K, et al. Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysis. Radiat Oncol J 2013; 31(3): 155-161.
Weisser M, Beets-Tan R and Beets G. Management of complete response after chemoradiation in rectal cancer. Surg Oncol Clin N Am 2014; 23 (1): 113-125.
Habr-Gama A, M.D., Perez RO, Nadalin W. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 2005; 9: 90-101.
Glynne-Jones R, Wallace M, Livingstone JIL, et al. Complete clinical response after preoperative chemoradiation in rectal cancer: Is a “wait and see” policy justified? Diseases of the Colon & Rectum 2008; 51: 10-20.
Habr-Gama A, de Souza PM, Ribeiro U, et al. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 1998; 41: 1087-1096.
Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy. Long-term Results. Ann Surg 2004; 240:711–718.
Habr-Gama A, Perez RO, Nadalin W. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 2005; 9: 90-101.
Habr-Gama A. Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy. Colorectal Disease 2006; 8(3): 21-24.
Habr-Gama A, Perez RO, Proscurshim I, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006; 10: 1319-1329.
Habr-Gama A, Perez RO, São Julião GP, et al. Nonoperative approaches to rectal cancer: A critical evaluation. Semin Radiat Oncol 2011; 21: 234-239.
Habr-Gama A, Perez RO, Wynn G, et al. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: Characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 2010; 53: 1692-1698.
Habr-Gama A, Perez R, Proscurshim I, et al. Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer. Surg Oncol Clin N Am 2010; 19: 829-845.
Perez RO, Habr-Gama A, Pereira GV, et al. Role of biopsies in patients with residual rectal cáncer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer? Colorectal Disease 2011; 14: 714-720.
Perez RO, Habr-Gama A, Sao Juliao GP, et al. Optimal Timing for Assessment of Tumor Response to Neoadjuvant Chemoradiation in Patients with Rectal Cancer: Do All Patients Benefit from Waiting Longer than 6 Weeks? Int J Radiat Oncol Biol Phys 2012; 84(5): 1159-1165.
Perez RO, Habr-Gama A, Lynn PB, et al. Transanal Endoscopic Microsurgery for Residual Rectal Cancer (ypT0-2) Following Neoadjuvant Chemoradiation Therapy: Another Word of Caution. Dis Colon Rectum 2013; 56: 6-13.
Habr-Gama A, Sabbaga J, Gama-Rodrigues J, et al. Watch and Wait Approach Following Extended Neoadjuvant Chemoradiation for Distal Rectal Cancer: Are We Getting Closer to Anal Cancer Management? Dis Colon Rectum 2013; 56: 1109-1117.
Bonnetain F, Bosset JF, Gerard JP, et al. What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question?. European Journal of Cancer 2012; 48 (12): 1781-1790.
O’Neill BP, Brown G, Heald RJ. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 2007; 8: 625-633.
De Nardi P, Carvello M. How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy? World J Gastroenterol 2013; 19(36): 5964-5972.
Hughes R, Harrison M, Glynne-Jones R. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy? Acta Oncológica 2010; 49: 378-381.
Dalton RSJ, Velineli R, Osborne ME, et al. A single centre experience of chemoradiotherapy for rectal cancer: Is there potential for nonoperative management? Colorectal Disease 2011; 14: 567-571.
Lim L, Chao M, Shapiro J, et al. Long-Term Outcomes of Patients with Localized Rectal Cancer Treated with Chemoradiation or Radiotherapy Alone Because of Medical Inoperability or Patient Refusal. Dis Colon Rectum 2007; 50: 2032-2039.
Neuman HB, Elkin EB, JG Guillem, et al. Treatment for Patients with Rectal Cancer and a Clinical Complete Response to Neoadjuvant Therapy: A Decision Analysis. Dis Colon Rectum 2009; 52 (5): 863-871.
Mignanelli ED, Campos-Lobato LF, Stocchi L, et al. Down staging after chemoradiotherapy for locally advanced rectal cancer: Is there more (tumor) than meets the eye? Diseases of the Colon & Rectum 2010; 53: 251-256.
Higgins KA, Willett CG, Czito BG. Nonoperative management of rectal cancer: Current perspectives. Clinical Colorectal Cancer 2010; 9(2): 83-88.
Maas M, Nelemans PJ, Valentini V, et al. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835-44.
Rullier E, Denost Q, Vendrely V, et al. Low Rectal Cancer: Classification and Standardization of Surgery. Dis Colon Rectum 2013; 56: 560-567.
Smith FM, Waldron D, Winter DC. Rectum-conserving surgery in the era of chemoradiotherapy. Br J Surg 2010; 97:1752-1764.
Nyasavajjala SM, Shaw AG, Khan AQ, et al. Neoadjuvant chemo-radiotherapy and rectal cancer: can the UK watch and wait with Brazil? Colorectal Disease 2010; 12: 33–36.
Fischkoff KN, Ruby JA, Guillem JG. Nonoperative approach to locally advance rectal cancer after neoadjuvant combined modality therapy: Challenges and opportunities from a surgical perspective. Clinical Colorectal Cancer 2011; 10(4): 291-7.
Martin ST, Heneghan MH, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. British Journal of Surgery 2012; 99: 918-928.
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
